Crossref journal-article
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences (341)
Abstract

We have designed MI-219 as a potent, highly selective and orally active small-molecule inhibitor of the MDM2–p53 interaction. MI-219 binds to human MDM2 with a K i value of 5 nM and is 10,000-fold selective for MDM2 over MDMX. It disrupts the MDM2–p53 interaction and activates the p53 pathway in cells with wild-type p53, which leads to induction of cell cycle arrest in all cells and selective apoptosis in tumor cells. MI-219 stimulates rapid but transient p53 activation in established tumor xenograft tissues, resulting in inhibition of cell proliferation, induction of apoptosis, and complete tumor growth inhibition. MI-219 activates p53 in normal tissues with minimal p53 accumulation and is not toxic to animals. MI-219 warrants clinical investigation as a new agent for cancer treatment.

Bibliography

Shangary, S., Qin, D., McEachern, D., Liu, M., Miller, R. S., Qiu, S., Nikolovska-Coleska, Z., Ding, K., Wang, G., Chen, J., Bernard, D., Zhang, J., Lu, Y., Gu, Q., Shah, R. B., Pienta, K. J., Ling, X., Kang, S., Guo, M., … Wang, S. (2008). Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition. Proceedings of the National Academy of Sciences, 105(10), 3933–3938.

Authors 22
  1. Sanjeev Shangary (first)
  2. Dongguang Qin (additional)
  3. Donna McEachern (additional)
  4. Meilan Liu (additional)
  5. Rebecca S. Miller (additional)
  6. Su Qiu (additional)
  7. Zaneta Nikolovska-Coleska (additional)
  8. Ke Ding (additional)
  9. Guoping Wang (additional)
  10. Jianyong Chen (additional)
  11. Denzil Bernard (additional)
  12. Jian Zhang (additional)
  13. Yipin Lu (additional)
  14. Qingyang Gu (additional)
  15. Rajal B. Shah (additional)
  16. Kenneth J. Pienta (additional)
  17. Xiaolan Ling (additional)
  18. Sanmao Kang (additional)
  19. Ming Guo (additional)
  20. Yi Sun (additional)
  21. Dajun Yang (additional)
  22. Shaomeng Wang (additional)
Dates
Type When
Created 17 years, 5 months ago (March 3, 2008, 8:54 p.m.)
Deposited 3 years, 4 months ago (April 12, 2022, 5:02 p.m.)
Indexed 1 month, 1 week ago (July 22, 2025, 6:56 a.m.)
Issued 17 years, 5 months ago (March 11, 2008)
Published 17 years, 5 months ago (March 11, 2008)
Published Online 17 years, 5 months ago (March 11, 2008)
Published Print 17 years, 5 months ago (March 11, 2008)
Funders 0

None

@article{Shangary_2008, title={Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition}, volume={105}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.0708917105}, DOI={10.1073/pnas.0708917105}, number={10}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Shangary, Sanjeev and Qin, Dongguang and McEachern, Donna and Liu, Meilan and Miller, Rebecca S. and Qiu, Su and Nikolovska-Coleska, Zaneta and Ding, Ke and Wang, Guoping and Chen, Jianyong and Bernard, Denzil and Zhang, Jian and Lu, Yipin and Gu, Qingyang and Shah, Rajal B. and Pienta, Kenneth J. and Ling, Xiaolan and Kang, Sanmao and Guo, Ming and Sun, Yi and Yang, Dajun and Wang, Shaomeng}, year={2008}, month=mar, pages={3933–3938} }